Abstract: [Object] Provided is a power supply rail capable of continuing to stably supply electric power from a power supply of a vehicle to a slide seat. [Solving Means] A power supply rail 1 according to the present invention is configured by including a long tubular case 8, a flexible flat cable 11 accommodated in a hollow portion 9 in the case 8, a fixed terminal 12 fixed to the case 8, a movable terminal 13 movable in a longitudinal direction of the case 8, an actuator 16 that accommodates the movable terminal 13 and moves along a slit 20 of the case 8, and a guide plate 17 that guides the movement of the flexible flat cable 11 while pressing the flexible flat cable 11 in accordance with the movement of the actuator 16.

Abstract: [Object] Provided is a power supply rail capable of continuing to stably supply electric power from a power supply of a vehicle to a slide seat. [Solving Means] A power supply rail 1 according to the present invention is configured by including a long tubular case 8, a flexible flat cable 11 accommodated in a hollow portion 9 in the case 8, a fixed terminal 12 fixed to the case 8, a movable terminal 13 movable in a longitudinal direction of the case 8, an actuator 16 that accommodates the movable terminal 13 and moves along a slit 20 of the case 8, and a guide plate 17 that guides the movement of the flexible flat cable 11 while pressing the flexible flat cable 11 in accordance with the movement of the actuator 16.

Abstract: There are provided an air conditioning apparatus and air conditioning method for cooling a passenger space of a vehicle that accommodates a user. The air conditioning apparatus includes a tank that is capable of storing compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. Energy that is generated without putting a workload on the power source or electric power of the vehicle is used for at least one process of compressing air in the tank, cooling the compressed air stored in the tank, and heating the compressed air stored in the tank.

Abstract: An air conditioning apparatus and an air conditioning method for cooling a passenger space of a vehicle that accommodates a user include a tank that is capable of storing compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. Energy that is generated without putting a workload on the power source or electric power of the vehicle is used for at least one process of compressing air in the tank, cooling the compressed air stored in the tank, and heating the compressed air stored in the tank.

Abstract: There are provided a vehicle, a cooling apparatus, and a cooling method. The vehicle includes passenger space to accommodate a user gets, a tank to store the compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. The passenger space is cooled by discharging the compressed air into the passenger space.

Abstract: There are provided a vehicle, a cooling apparatus, and a cooling method. The vehicle includes passenger space that accommodates a user, a tank that is capable of storing compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. The control unit controls releasing so as to release part or the whole volume of the compressed air stored in the tank into the passenger space.

Abstract: There are provided a vehicle, a cooling apparatus, and a cooling method. The vehicle includes passenger space to accommodate a user gets, a tank to store the compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. The passenger space is cooled by discharging the compressed air into the passenger space.

Abstract: There are provided a vehicle, a cooling apparatus, and a cooling method. The vehicle includes passenger space that accommodates a user, a tank that is capable of storing compressed air, and a control unit to release the compressed air stored in the tank into the passenger space. The control unit controls releasing so as to release part or the whole volume of the compressed air stored in the tank into the passenger space.

Abstract: DNA fragments having a nucleotide sequence represented by x and vectors containing the DNA fragment, wherein the nucleotide sequence x encodes an amino acid sequence represented by any one of the following formulae 1 to 8:formula 1 AVLPQEEEGSG,formula 2 AVLPQEEEGSGGGQLVTEVTKKEDSG,formula 3 AVLDQEEEGSG,formula 4 AVLPQEEEGDG,formula 5 AVLPQEEEGSGD,formula 6 AVLPQEEEGSGDD,formula 7 AVLPQEEEGSGDDD, andformula 8 ADDPQEEEGSG.Expression of a protein of interest and its secretion from host cells into the extracellular milieu can be increased by expressing or secreting the protein of interest in the form of a fusion protein with a specified polypeptide encoded by the DNA fragment of the present invention using the vector of the present invention, by means of recombinant DNA techniques in which the inventive DNA fragment is used.

Abstract: This invention provides a novel polypeptide which comprises an amino acid sequence that constitutes a portion of urinary trypsin inhibitor (UTI) and which has no antigenicity against human and high activity to inhibit various proteases, as well as other novel polypeptides having excellent activities to inhibit various proteases obtained by mutation of the former novel polypeptide. This invention also provides novel enzyme inhibition processes, drug compositions and treating methods making use of the novel polypeptide, DNA fragments containing nucleotide sequences which encode the novel polypeptides, vectors containing the DNA fragments and transformants transformed with the DNA fragments or the vectors, as well as processes for the production of the novel polypeptides.

Abstract: This invention relates to novel vectors and host cells containing nucleic acids coding for a polypeptide having thrombin binding ability, anticoagulant activity and thrombolytic activity. The polypeptide can be efficiently produced in large quantities by means of genetic recombination techniques using the vectors and host cells of the present invention. Since the polypeptide exhibits anticoagulant activity and thrombolytic activity without generating side effects such as bleeding tendencies, it can be applied effectively to the prevention and treatment of hypercoagulability-related diseases.

Abstract: This invention particularly provides a novel polypeptide having high protease-inhibiting activity, preferably FXa-inhibiting activity, which comprises, at least as a part of the polypeptide, an amino acid sequence resulting from substitution of an amino acid for at least one amino acid in the following amino acid sequence (1), wherein the amino acid substitution is at least one substitution selected from the following substitution means (i) to (iii). It also provides a process for the production of the polypeptide, a novel DNA fragment encoding the polypeptide and a drug composition containing the same.Amino acid sequence (1) ##STR1## (i) Substitution of 15 position Gln counting from the N-terminus by an amino acid other than Gln.(ii) Substitution of 42 position Tyr counting from the N-terminus by an amino acid other than Tyr.(iii) Substitution of 7 position Arg counting from the N-terminus by an amino acid other than Arg.

Abstract: This invention particularly provides a novel polypeptide having high protease-inhibiting activity, preferably FXa-inhibiting activity, which comprises, an lease as a part of the polypeptide, an amino acid sequence resulting from substitution of an amino acid for at least one amino acid in the following amino acid sequence (1), wherein the amino acid substitution is at least one substitution selected from the following substitution means (i) to (iii). It also provides a process for the production of the polypeptide, a novel DNA fragment encoding the polypeptide and a drug composition containing the same.

Abstract: This invention relates to a novel polypeptide which is obtained by means of genetic recombination DNA techniques and has thrombin binding ability, anticoagulant activity and thrombolytic activity. The polypeptide of the present invention can be produced in a large quantity and efficiently by means of genetic recombination techniques. Since the polypeptide of the present invention exhibits anticoagulant activity and thrombolytic activity without generating side effects such as bleeding tendency, it can be applied effectively to the prevention and treatment of hypercoagulability-related diseases.

Abstract: This invention particularly provides a novel polypeptide having high protease-inhibiting activity, preferably FXa-inhibiting activity, which comprises, at least as a part of the polypeptide, an amino acid sequence resulting from substitution of an amino acid for at least one amino acid in the following amino acid sequence (1), wherein the amino acid substitution is at least one substitution selected from the following substitution means (i) to (iii). It also provides a process for the production of the polypeptide, a novel DNA fragment encoding the polypeptide and a drug composition containing the same.

Abstract: This invention provides a novel polypeptide which comprises an amino acid sequence that constitutes a portion of urinary trypsin inhibitor (UTI) and which has no antigenicity against human and high activity to inhibit various proteases, as well as other novel polypeptides having excellent activities to inhibit various proteases obtained by mutation of the former novel polypeptide. This invention also provides novel enzyme inhibition processes, drug compositions and treating methods making use of the novel polypeptide, DNA fragments containing nucleotide sequences which encode the novel polypeptides, vectors containing the DNA fragments and transformants transformed with the DNA fragments or the vectors, as well as processes for the production of the novel polypeptides.